Department of Population, Family and Reproductive Health, Center for the Early Life Origins of Disease, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Department of Pathology, Johns Hopkins University, Baltimore, MD.
Am J Kidney Dis. 2021 Jun;77(6):879-888.e1. doi: 10.1053/j.ajkd.2020.10.020. Epub 2020 Dec 22.
RATIONALE & OBJECTIVES: Preeclampsia, which disproportionately affects Black women, is a leading cause of preterm delivery and risk for future hypertension and chronic kidney disease (CKD). Apolipoprotein L1 (APOL1) kidney risk alleles, common among Black individuals, contribute substantially to CKD disparities. Given the strong link between preeclampsia and CKD, we investigated whether maternal and fetal APOL1 risk alleles can jointly influence preeclampsia risk, and explored potential modifiers of the association between APOL1 and preeclampsia.
Nested case-control study.
SETTING & PARTICIPANTS: 426 Black mother-infant pairs (275 African Americans and 151 Haitians) from the Boston Birth Cohort.
Maternal and fetal APOL1 risk alleles.
Preeclampsia.
Logistic regression models with adjustment for demographic characteristics were applied to analyze associations between fetal and maternal APOL1 risk alleles and risk of preeclampsia and to investigate the effects of modification by maternal country of origin.
Fetal APOL1 risk alleles tended to be associated with an increased risk of preeclampsia, which was not statistically significant in the total genotyped population. However, this association was modified by maternal country of origin (P<0.05 for interaction tests): fetal APOL1 risk alleles were significantly associated with an increased risk of preeclampsia among African Americans under recessive (odds ratio [OR], 3.6 [95% CI, 1.3-9.7]; P=0.01) and additive (OR, 1.7 [95% CI, 1.1-2.6]; P=0.01) genetic models but not in Haitian Americans. Also, maternal-fetal genotype discordance at the APOL1 locus was associated with a 2.6-fold higher risk of preeclampsia (P<0.001) in African Americans.
Limited sample size in stratified analyses; self-reported maternal country of origin; pre-pregnancy estimated glomerular filtration rate (eGFR) and proteinuria data in mothers were not collected; unmeasured confounding social and/or environmental factors; no replication study.
This study supports the hypothesis that fetal APOL1 kidney risk alleles are associated with increased risk for preeclampsia in a recessive mode of inheritance in African Americans and suggests that maternal-fetal genotype discordance is also associated with this risk. These conclusions underscore the need to better understand maternal-fetal interaction and their genetic and environmental factors as contributors to ethnic disparities in preeclampsia.
子痫前期发病率在黑人群体中明显更高,它是早产和未来高血压及慢性肾病(CKD)风险的主要原因。载脂蛋白 L1(APOL1)基因风险等位基因在黑人群体中较为常见,与 CKD 发病率的差异有很大关系。鉴于子痫前期与 CKD 之间的紧密联系,我们研究了母体和胎儿的 APOL1 风险等位基因是否可以共同影响子痫前期的发病风险,并探讨了 APOL1 与子痫前期之间关联的潜在修饰因素。
嵌套病例对照研究。
来自波士顿出生队列的 426 对黑人生育母婴(275 名非裔美国人和 151 名海地人)。
母体和胎儿的 APOL1 风险等位基因。
子痫前期。
采用 logistic 回归模型,调整人口统计学特征后,分析胎儿和母体 APOL1 风险等位基因与子痫前期发病风险之间的关联,并探讨母国来源对其的修饰作用。
胎儿的 APOL1 风险等位基因与子痫前期的发病风险增加有关,但在总基因分型人群中,这种关联没有统计学意义。然而,这种关联受到母体母国来源的修饰(交互检验 P<0.05):在非裔美国人中,APOL1 风险等位基因在隐性(比值比 [OR],3.6 [95% CI,1.3-9.7];P=0.01)和加性(OR,1.7 [95% CI,1.1-2.6];P=0.01)遗传模型中与子痫前期发病风险增加显著相关,但在海地裔美国人中无此相关性。此外,APOL1 基因座的母体-胎儿基因型不匹配与非裔美国人子痫前期的发病风险增加 2.6 倍相关(P<0.001)。
分层分析中样本量有限;母亲的母国来源为自我报告;母亲在怀孕前的估计肾小球滤过率(eGFR)和蛋白尿数据未收集;未测量的混杂社会和/或环境因素;无复制研究。
本研究支持了这样一种假说,即胎儿的 APOL1 肾脏风险等位基因以隐性遗传模式与非裔美国人子痫前期的发病风险增加有关,并提示母体-胎儿基因型不匹配也与这种风险相关。这些结论强调了需要更好地了解母体-胎儿相互作用及其遗传和环境因素,以解释子痫前期的种族差异。